| [1] |
Torre LA,Bray F,Siegel RL,et al.Global cancer statistics,2012[J].CA Cancer J Clin,2015,65(2):87-108.
|
| [2] |
Herbst RS,Heymach JV,Lippman SM.Lung cancer[J].N Engl J Med,2008,359(13):1367-1380.
|
| [3] |
Johnson BE,Janne PA.Epidermal growth factor receptor mutations in patients with non-small cell lung cancer[J].Cancer Res,2005,65(17):7525-7529.
|
| [4] |
Govindan R.A review of epidermal growth factor receptor/HER2 inhibitors in the treatment of patients with non-small-cell lung cancer[J].Clin Lung Cancer,2010,11(1):8-12.
|
| [5] |
Finlay MR,Anderton M,Ashton S,et al.Discovery of a potent and selective EGFR inhibitor(AZD9291)of both sensitizing and T790M resistance mutations that spares the wild type form of the receptor[J].J Med Chem,2014,57(20):8249-8267.
|
| [6] |
Walter AO,Sjin RT,Haringsma HJ,et al.Discovery of a mutant-selective covalent inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC[J].Cancer Discov,2013,3(12):1404-1415.
|
| [7] |
Zhou W,Ercan D,Chen L,et al.Novel mutant-selective EGFR kinase inhibitors against EGFR T790M[J].Nature,2009,462(7276):1070-1074.
|
| [8] |
Basudhar D,Ridnour LA,Cheng R,et al.Biological signaling by small inorganic molecules[J].Coord Chem Rev,2016,306(Pt 2):708-723.
|
| [9] |
Huang Z,Fu J,Zhang Y.Nitric oxide donor-based cancer therapy:advances and prospects[J].J Med Chem,2017,60(18):7617-7635.
|
| [10] |
Cheng H,Wang L,Mollica M,et al.Nitric oxide in cancer metastasis[J].Cancer Lett,2014,353(1):1-7.
|
| [11] |
Han C,Huang Z,Zheng C,et al.Novel hybrids of(phenylsulfonyl)furoxan and anilinopyrimidine as potent and selective epidermal growth factor receptor inhibitors for intervention of non-small-cell lung cancer[J].J Med Chem,2013,56(11):4738-4748.
|
| [12] |
Han C,Huang Z,Zheng C,et al.Nitric oxide donating anilinopyrimidines:synthesis and biological evaluation as EGFR inhibitors[J].Eur J Med Chem,2013,66:82-90.
|
| [13] |
Han C,Wan L,Ji H,et al.Synthesis and evaluation of 2-anilinopyrimidines bearing 3-aminopropamides as potential epidermal growthfactor receptor inhibitors[J].Eur J Med Chem,2014,77:75-83.
|
| [14] |
Huang Z,Kaur J,Bhardwaj A,et al.O2-sulfonylethyl protected isopropylamine diazen-1-ium-1,2-diolates as nitroxyl(HNO)donors:synthesis,beta-elimination fragmentation,HNO release,positive inotropic properties,and blood pressure lowering studies[J].J Med Chem,2012,55(22):10262-10271.
|
| [15] |
Hong SY,Saavedra JE,Keefer LK,et al.Improved synthesis of V-PYRRO/NO,a liverselective nitric oxide prodrug,and analogues[J].Tetrahedron Lett,2009,50(18):2069-2071.
|
| [16] |
Hamann JN,Rolff M,Tuczek F.Monooxygenation of an appended phenol in a model system of tyrosinase:implications on the enzymatic reaction mechanism[J].Dalton Trans,2015,44(7):3251-3258.
|
下载:
